We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03787602
Brief Title: Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma

First Submitted : December 6, 2018
First Submitted that Met QC Criteria : December 21, 2018
First Posted : December 26, 2018

Last Update Submitted that Met QC Criteria : August 3, 2022
Last Update Posted : August 4, 2022